Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Isthmus Logic Post Market Clinical Follow-up Study
Sponsor: CID S.p.A.
Summary
Isthmus Logic Carbostent™ is a CE-marked cobalt chromium stent with a bio inducer surface for the treatment of peripheral iliac artery disease. The aim of this post-market retrospective study protocl P22202 is to collect clinical data of patients treated with Isthmus Logic for the treatment of peripheral iliac artery disease in routine clinical practice. In order to obtain long-term follow-up data, the data collection will be limited to patients that have been treated with these devices at least 12 months prior to the study start.
Official title: A Cobalt Chromium Stent With a Bio Inducer Surface for the Treatment of Peripheral Iliac Artery Disease: Evaluation of Safety and Performance in Everyday Clinical Practice. The Isthmus Logic Post Market Clinical Follow-up Study.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
37
Start Date
2023-09-04
Completion Date
2024-05-22
Last Updated
2026-10-22
Healthy Volunteers
No
Conditions
Interventions
Isthmus Logic
Patient implanted with Isthmus Logic stent for the treatment of peripheral iliac artery disease
Locations (1)
Ospedale San Raffaele
Milan, Italy